
Azacytin 200mg Tablet
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Azacitidine (200mg)
Overview Azacytin 200mg Tablet
Azacytidine 200mg tablets are indicated in the management of certain hematological malignancies. Specifically, they're employed in treating adult patients across all Myelodysplastic Syndrome (MDS) subtypes. Other uses may be determined by a physician. This medication may be ingested with or without food, but consistent daily timing is recommended. Dosage and frequency are individualized by your doctor, based on your condition and may be adjusted. Adhere strictly to your physician's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent immediately; continue treatment as prescribed unless instructed otherwise. Common side effects encompass nausea, emesis, fatigue, and pyrexia. Report any concerning symptoms to your doctor; mitigation strategies may be available. Vaccination during therapy requires prior physician consultation. Regular monitoring of blood counts, hepatic, renal, and cardiac function is essential. Prior to commencing treatment, disclose any existing hepatic or renal impairment, and all concurrent medications, particularly anti-infectives, as drug interactions are possible. This medication is contraindicated during gestation and lactation.
Primary Ingredients of Azacytin 200mg Tablet
No text provided to rephrase.
Uses of Azacytin 200mg Tablet
Myelodysplastic syndrome: Blood cancer therapies
Major Benefits of Azacytin 200mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Azacytin 200mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Azacytin 200mg Tablet:
- Vomiting
- Weakness
- Nausea
- Decreased potassium level in blood
- Bruise
- Fever
- Chills
- Diarrhea
- Constipation
How to use Azacytin 200mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 200mg Azacytin tablet can be consumed with or without food, though consistent timing is recommended.
How Azacytin 200mg Tablet works:
Vidaza (azacytin) 200mg tablets are a leukemia treatment that inhibits the development of cancerous genetic material (DNA and RNA). This action leads to the death of leukemia cells and promotes the healthy production and maturation of new blood cells within the bone marrow.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Azacytin 200mg tablets is currently undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Azacytin 200mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should not take Azacytin 200mg tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Azacytin 200mg Tablets, including fatigue. Azacytin 200mg Tablets may induce tiredness, potentially impacting driving safety.
KidneyCAUTION
Patients with kidney impairment should use Azacytin 200mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Azacytin 200mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Azacytin 200mg tablets are contraindicated in individuals with progressed hepatic malignancy.
What if you forget to take Azacytin 200mg Tablet :
NA
Facts to Know About Azacytin 200mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Pyrimidine Nucleoside Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Metabolic Inhibitors |
